330 related articles for article (PubMed ID: 830773)
1. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
Goldsmith GH; Stern RC; Saito H; Ratnoff OD
J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
[TBL] [Abstract][Full Text] [Related]
3. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
Bury AF; Barrett AJ
Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
[TBL] [Abstract][Full Text] [Related]
4. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
5. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
Saito H
J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
[TBL] [Abstract][Full Text] [Related]
6. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
7. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
[TBL] [Abstract][Full Text] [Related]
8. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Kallen RJ; Lee SK
Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
[TBL] [Abstract][Full Text] [Related]
9. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
10. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
Gordon EM; Ratnoff OD; Goldsmith GH
J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
[TBL] [Abstract][Full Text] [Related]
11. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
[TBL] [Abstract][Full Text] [Related]
12. Participation of Hageman factor dependent pathways in human disease states.
Colman RW; Wong PY
Thromb Haemost; 1977 Dec; 38(4):751-75. PubMed ID: 341410
[TBL] [Abstract][Full Text] [Related]
13. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
[TBL] [Abstract][Full Text] [Related]
15. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
Kaplan AP; Meier HL; Mandle RJ
Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
[No Abstract] [Full Text] [Related]
16. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
17. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
18. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Mandle RJ; Colman RW; Kaplan AP
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
[TBL] [Abstract][Full Text] [Related]
19. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
Donaldson VH; Kleniewski J; Saito H; Sayed JK
J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
[TBL] [Abstract][Full Text] [Related]
20. Contact activation of human plasma prorenin in vitro.
Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
